Overview

Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance

Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Dual medication (guanfacine and morphine) as a standard treatment for chronic pain.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
National Institute on Drug Abuse (NIDA)
National Institutes of Health (NIH)
Treatments:
Guanfacine
Morphine
Polystyrene sulfonic acid